EMD-48101

Single-particle
4.18 Å
EMD-48101
3D View Gallery
Deposition: 27/11/2024
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48101
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9eje summary report (pdf.gz) Map and 9eje FULL report (pdf.gz)
EMICSS annotations (xml)

NCS.1 Fab in complex with N5 NA of A/shorebird/Delaware Bay/309/2016 (DB16, H10N5) -- 3 Fabs

EMD-48101

Single-particle
4.18 Å
EMD-48101
3D View Gallery
Deposition: 27/11/2024
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Influenza A virus
Sample: NCS.1 Fab in complex with N5 NA of A/shorebird/Delaware Bay/309/2016 (DB16, H10N5) -- 3 Fabs
Fitted models: 9eje

Deposition Authors: Borst AJ
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies.
Lederhofer J , Borst AJ , Nguyen L, Gillespie RA , Williams CJ, Walker EL, Raab JE, Yap C, Ellis D, Creanga A , Tan HX, Do THT, Ravichandran M , McDermott AB , Le Sage V, Andrews SF , Graham BS, Wheatley AK , Reed DS , King NP , Kanekiyo M
(2025) Nat Commun , 16 , 7068 - 7068
PUBMED: 40750617
DOI: doi:10.1038/s41467-025-62339-z
ISSN: 2041-1723
Grant Support: